- Home
- FF vs TIL Comparison
FF vs TIL Comparison
Compare FF & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- TIL
- Stock Information
- Founded
- FF N/A
- TIL 2018
- Country
- FF United States
- TIL United States
- Employees
- FF N/A
- TIL N/A
- Industry
- FF Major Chemicals
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- FF Industrials
- TIL Health Care
- Exchange
- FF Nasdaq
- TIL Nasdaq
- Market Cap
- FF 180.0M
- TIL 171.7M
- IPO Year
- FF N/A
- TIL 2021
- Fundamental
- Price
- FF $4.12
- TIL $13.23
- Analyst Decision
- FF Strong Buy
- TIL Buy
- Analyst Count
- FF 1
- TIL 5
- Target Price
- FF $0.80
- TIL $114.00
- AVG Volume (30 Days)
- FF 268.1K
- TIL 179.4K
- Earning Date
- FF 05-12-2025
- TIL 05-20-2025
- Dividend Yield
- FF 5.83%
- TIL N/A
- EPS Growth
- FF N/A
- TIL N/A
- EPS
- FF 0.35
- TIL N/A
- Revenue
- FF $243,339,000.00
- TIL N/A
- Revenue This Year
- FF N/A
- TIL N/A
- Revenue Next Year
- FF N/A
- TIL N/A
- P/E Ratio
- FF $11.66
- TIL N/A
- Revenue Growth
- FF N/A
- TIL N/A
- 52 Week Low
- FF $3.77
- TIL $9.62
- 52 Week High
- FF $6.40
- TIL $92.00
- Technical
- Relative Strength Index (RSI)
- FF 52.30
- TIL 44.22
- Support Level
- FF $3.91
- TIL $11.97
- Resistance Level
- FF $4.19
- TIL $14.67
- Average True Range (ATR)
- FF 0.12
- TIL 2.05
- MACD
- FF 0.02
- TIL -0.04
- Stochastic Oscillator
- FF 74.11
- TIL 17.87
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.